Posted by keown83 > 2020-11-09 17:27 | Report Abuse

i think market will become ridiculous for a time being before it make sense once again

Posted by samsungtrader > 2020-11-09 17:35 | Report Abuse

2 types of stock player.. 1st swing player.. 2nd long term pLyer.. so ur strategy is based on what type of traders are u.. trade

Posted by Nicolas Nelson Ong > 2020-11-09 17:42 | Report Abuse

Hooray Happy mew year ....Londom br8dge is falling down.....congrats to all ......

Posted by mf > 2020-11-09 21:50 | Report Abuse

gap down

Posted by tablesalt > 2020-11-09 22:09 | Report Abuse

Oh my god, really mf? What are the Ruberex investors going to do after this? :(

Posted by gemfinder > 2020-11-09 22:16 | Report Abuse

https://www.theedgemarkets.com/article/pfizer-biontech-say-their-covid19-vaccine-more-90-effective

Posted by KHSL64 > 2020-11-09 22:31 | Report Abuse

The vaccine is still not yet been approved by US FDA. Let's wait and see.

Posted by Mystereo4 > 2020-11-09 22:53 | Report Abuse

Pfizer now expect to produce up to 50 million doses or enough vaccine to protect 25 million people this year.

Not even enough to achieve herd immunity since at least 70% global population has to be vaccinated

Posted by MMMMM > 2020-11-09 23:07 | Report Abuse

Pfizer 90% is based on 94 patients only. please read news. thanks. Can't even get 100% with only 94 patients.

https://www.buzzfeednews.com/article/azeenghorayshi/coronavirus-vaccine-pfizer-results - does not include actual data...

Posted by tamarindo > 2020-11-09 23:15 | Report Abuse

94 patients only. what a joke!

Posted by keown83 > 2020-11-09 23:40 | Report Abuse

Pfizer shares dropped 7% from their previous 14% gapped up increment earlier..some people must have lost 50% of their entry money there..poor them

Posted by ming > 2020-11-09 23:42 | Report Abuse

Ruberex drop -20% then back to -10% then.. xD

Posted by Sinoboy > 2020-11-09 23:56 | Report Abuse

When panic sellers realise that they've been duped, it will be too late...

Posted by Plantermen > 2020-11-10 07:16 | Report Abuse

Expect trading volatility in Glove producers. Small players will follow the big 4 trend

Posted by 1Anchovy > 2020-11-10 08:16 | Report Abuse

https://www.cnbc.com/2020/11/09/dr-scott-gottlieb-pfizer-covid-vaccine-wont-help-immediately.html?__source=androidappshare

Posted by Chua Joe Beng > 2020-11-10 08:54 | Report Abuse

Rubberex 3QR should b out early anytime this week.

Posted by yiqqre > 2020-11-10 08:58 | Report Abuse

手套售价走高 ·来百利第三季盈利看俏
Sinchew Mon, Nov 09, 2020 08:29pm - 12 hours ago


洪建文／报道

（吉隆坡9日讯）来百利机构（RUBEREX,7803,主板工业产品服务组）将在月杪公布2020财政年第三季财报，兴业研究考量第三季手套售价走高，预期第三季盈利可能按季翻倍，按年增幅更可能超过10倍。

兴业研究说：“以贺特佳（HARTA,5168,主板医疗保健组）和速柏玛（SUPERMX,7106,主板医疗保健组）财报和展望来看，我们可能低估手套平均售价涨幅，主要是全球冠病疫情恶化和丁腈（nitrile）原料短缺。”

该行补充，丁腈手套需求空前，促使丁腈原料需求暴增，价格更是自9月起每月增长20%，凸显出买家愿意以更高的价格扫货。

“若情况持续至2021年第一季，这可能导致丁腈手套价格涨势长于预期。”

新厂贡献 第四季盈利料更好
目前，丁腈手套占来百利机构2019财政年总营业额约45%，而兴业研究预期营业额贡献比重将在2021财政年进一步增加至80%。

与此同时，来百利机构已完成新厂建设，并在进行最后一轮的试运行，兴业研究预期新厂将在12月开始带来盈利贡献，看好第四季盈利将更好。

“一旦新厂在12月准备就绪，届时来百利机构丁腈手套有望按季飙升150%，从现有每年10亿只增加至25亿只。”

整体来说，兴业研究看好来百利机构高于预期的平均售价，将推高2020财政年第三季盈利表现，同时新生产线于第四季投入使用，也将提高丁腈手套产量按季增长150%，上调2021至2023财政年核心盈利48至136%，并维持“买进”

评级，目标价也从2令吉20仙调高至3令吉。

Posted by yiqqre > 2020-11-10 09:12 | Report Abuse

With vaccines, medical workers also need gloves。

Posted by kdginvest > 2020-11-10 09:17 | Report Abuse

GLOVE STOCKS GOING TO LIMIT UP THIS WEEK.

Posted by LOOK009 > 2020-11-10 09:20 | Report Abuse

Rest assured that the demand for gloves will not decrease. Who dares to be a white mouse with a vaccine?

Posted by 654321aaa > 2020-11-10 09:20 | Report Abuse

Almost limit down indeed...Up side down.

Posted by 654321aaa > 2020-11-10 09:21 | Report Abuse

Show good profits then gone down..

Posted by Snowpiercer > 2020-11-10 09:39 | Report Abuse

Strong fundamental rebounding from knee jerk. Nothing to worry. Enjoy the ride.

Posted by keown83 > 2020-11-10 09:41 | Report Abuse

pity those who panic selling & enter vaccine counter hoping for a hot goreng to cover loses..vaccine counters already losing steam right now after the gap up opening, glove counters on the other hand retaliate with strong buy by those to took opportunity to reenter with so much discount price

Posted by dusti > 2020-11-10 09:42 | Report Abuse

Agree with you LOOK009, glove is featured in SOPs of medical services worldwide. Come to think of it should have bought at first bell, but unfortunately the mind doesn’t work that ...........no button to press. Good luck survivors!

Posted by xuxu > 2020-11-10 09:44 | Report Abuse

Those panic sold it amdui now hehe

Posted by samsungtrader > 2020-11-10 09:54 | Report Abuse

rilex and enjoy ur coffee at home.. :-)

Posted by Plantermen > 2020-11-10 10:07 | Report Abuse

Both have the core support. Glove for long term. Vaccine for current theme play

Posted by Nicolas Nelson Ong > 2020-11-10 10:23 | Report Abuse

Good Morning , Kids ! London bridge is dalling down ..........

Posted by samsungtrader > 2020-11-10 10:31 | Report Abuse

haha... funny Nicolas... always want to trap people to sell their ticket so that he can buy lower. Rilex nic.. whenever it falls down, someone will build it up again...

Posted by Finance4114 > 2020-11-10 10:45 | Report Abuse

Ong ong ...gong gong bark again.....like gong gong bark the mountain...
Very sure ong ong got zero share in hand....gong gong all the way...

Posted by TunDaim > 2020-11-10 10:46 | Report Abuse

will come back strong..

Posted by Nicolas Nelson Ong > 2020-11-10 10:47 | Report Abuse

Hahahahhaa ..... for those ask ppl buy for sure wana sell his tickets lol..... good luck kids ekekekekekekekeke.

Posted by samsungtrader > 2020-11-10 10:49 | Report Abuse

funny kid nic... haha

Posted by LOOK009 > 2020-11-10 11:01 | Report Abuse

After announcing a high dividend, all the people started rushing in again.

Posted by SIPang > 2020-11-10 11:16 | Report Abuse

Buy buy buy, if u believe glove

Posted by xuxu > 2020-11-10 11:25 | Report Abuse

smlm beli happy2 hari ni buang ka ? hehe

Posted by khy0100 > 2020-11-10 11:32 | Report Abuse

no holding power then kamlan la. no need gan jeong. fundatmental good, + above EMA 30 50. scare lan

Posted by xuxu > 2020-11-10 11:37 | Report Abuse

no vaccine lah, all run for what ?

Posted by kdginvest > 2020-11-10 11:37 | Report Abuse

GLOVE STOCKS WILL FLY THIS WEEK.

Posted by fifimao > 2020-11-10 11:47 | Report Abuse

Expected to hit RM 3. New plant profit up...EPF even invested 13% in Top Glov...shows they are expecting rubber stocks to up

Posted by LOOK009 > 2020-11-10 11:59 | Report Abuse

https://www.orientaldaily.com.my/news/international/2020/11/10/374420?fbclid=IwAR0liV4_vAJ35BD6WzK-3giN2YuDG3-FxKRFzUKsc99S3Bw8dsqc9Dm4Ml0

发布于 2020年11月10日 10时33分 • 最后更新 1小时前
【新冠肺炎】中国科兴疫苗出现严重不良反应　巴西暂停临床试验
FacebookTwitterMessengerCopy Link
跨国制药公司辉瑞（Pfizer）9日宣布，根据其研发的新冠病毒疫苗显示，该疫苗对防范新冠肺炎的有效率超过90%，鼓舞各界，美股更因此暴涨834点。不过其他疫苗开发就没有这么顺利了，巴西国家卫生监测局（Anvisa）11月9日在一份声明中称，由于中国科兴生物技术公司的疫苗出现严重不良反应，因此已暂停其临床试验。

根据《路透社》报导，位于巴西圣保罗州（São Paulo）的布坦坦研究所（Instituto Butantan）会就科兴疫苗测试中断，举行新闻发布会。

由圣保罗布坦坦研究所与中国科兴生物技术公司共同研发的新冠病毒疫苗，在10月29日出现严重不良反应，因此紧急暂停临床试验。Anvisa并未提供更多细节，也未提及案例是发生在哪个国家。同时也没有说明，为何发生在10月29日的事，待到现在才对外沟通。



巴西CBN广播电台（Central Brasileira de Notícias）11月9日称，暂停测试是因有志愿人士死亡，不过这消息尚未经Anvisa证实。CBN获得的资料显示，去世的志愿人士本身没感染新冠肺炎，其死因亦未明。当事件被报道后，Anvisa发出确认中断测试的命令。当局将成立委员会分析这个案。

巴西7月21日起对中国公司研发的疫苗进行人体测试。全国有逾9,000名自愿人士接种疫苗，他们的年龄介乎18至59岁。圣保罗州长多里亚（João Doria）当时称，如测试证实疫苗有效，布坦坦研究所2021年开始生产1.2亿剂疫苗，并在国内免费供应。

Posted by richcares > 2020-11-10 12:05 | Report Abuse

https://www.facebook.com/47298465905/posts/10157687255245906/?sfnsn=mo

Posted by xuxu > 2020-11-10 12:09 | Report Abuse

vaccine out talk only also drop so much, if really out ? hehe

Posted by wong > 2020-11-10 12:30 | Report Abuse

Glove stocks down, not part of Pfizer vaccine party
KUALA LUMPUR (Nov 10): While the world is celebrating Pfizer’s overnight announcement of a viable Covid-19 vaccine candidate, rubber glove stocks may not be part of the party.

Glove counters top the loser list after the morning bell today.
As at 10.20am, shares in rubber glove counters were among the top losers on Bursa Malaysia. Hartalega Holdings Bhd slid by 8.54% or RM1.54 to RM16.60, making it the top value loser on Bursa, followed by Supermax Corp Bhd, down 75 sen or 7.79% to RM8.88.
In the third place was Kossan Rubber Industries Bhd, which released a strong set of quarterly earnings yesterday, dropping 63 sen or 8.27% to RM6.88, valuing it at RM17.59 billion.
Top Glove Corp Bhd took the fifth place, falling 54 sen or 6.37% to RM7.94.

The smaller players were not spared from the selling pressure. Comfort Gloves Bhd fell 31 sen or 6.97% to RM4.14, Careplus Group Bhd shed 27 sen or 7.8% to RM3.19, and Rubberex Corp (M) Bhd lost 16 sen or 6.45% to RM2.32.

The Healthcare Index was dragged down by the glove stocks, declining by 1.78% or 73.47 points to 4,048.89.
Still, while there was a selldown across the rubber glove stocks, shares in companies tapped by the government to bottle and distribute a potential Covid-19 vaccine were rising.

In a note this morning, AmInvestment Bank Research reiterated its view that the market will continue to shift to predominantly pandemic-themed plays to a recovery-focused theme in December.

“We have been advocating for investors to lighten their positions in the 'pandemic play', i.e. glove stocks, and replace them with the 'recovery play'.

“With the latest positive news coming in a rather abrupt manner, we expect volatility as investors of glove stocks rush to the exit at the same time. The two FBM KLCI-weighted glove stocks, i.e. Top Glove and Hartalega, command a combined weighting of 13% to 14%,” AmInvestment Bank wrote in the strategy note.

Having downgraded the glove sector to "neutral" on Aug 25, 2020 from "overweight" on positive news of a vaccine, AmInvestment Bank was putting fair values (FVs) for glove stocks under its coverage under review with negative bias.
Still, it expects gains linked to recovery plays to be significantly offset by losses seen in pandemic plays, resulting in it maintaining its end-2020 KLCI target of 1,530 points despite the overwhelming good news.
To recap, Pfizer and its German partner BioNTech announced last night that their experimental Covid-19 vaccine was more than 90% effective with no serious safety concerns based on initial trial results, estimating that they can roll out up to 50 million doses this year for 25 million people and produce 1.3 billion doses in 2021.

Posted by TigerWoods > 2020-11-10 13:46 | Report Abuse

Parking at 2.20!

Posted by SmartServiceZ > 2020-11-10 14:00 | Report Abuse

it will start rebound back now..! no less than 2.26!! and rocket to 3.00 tomorrow!!

Posted by samsungtrader > 2020-11-10 14:14 | Report Abuse

it will take 2 days to rebound back... waiting at 2.1.. hopefully, someone will push the price down so that we can buy at the lowest price... hehe.. come to mama Pleaseeeeeeeee.....

Posted by Jokers2020 > 2020-11-10 14:15 | Report Abuse

i queue buy at 2.00..come to me..

Posted by kasrim > 2020-11-10 14:53 | Report Abuse

i just buy the current price..